Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force
February 03, 2023 06:00 ET
|
Vyant Bio, Inc.
Continuing to Explore Strategic Alternatives CHERRY HILL, N.J., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company...
AnPac Bio-Medical Science Announces Signing of US$5.2 Million of Definitive Investment Agreements
January 25, 2023 08:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 25, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
Oncotelic Initiates Clinical Trials Evaluating OT-101 against Metastatic Pancreatic Cancer
January 25, 2023 08:00 ET
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., Jan. 25, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the "Company" or "We"), a clinical stage biotechnology company, with a planned IPO of...
Bioxytran Interview at the Emerging Growth Conference
January 24, 2023 14:10 ET
|
BIOXYTRAN, INC.
- Wednesday, January 25, 2023 10:50 am –11:20am EST - Discussion of the Biotech Showcase Conference BOSTON, MASSACHUSETTS, Jan. 24, 2023 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the...
AnPac Bio-Medical Sciences Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing
January 20, 2023 16:30 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
New York, NY, Jan. 20, 2023 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (the “Company”) (Nasdaq: ANPC), a biotechnology company with operations in the United States and China focused on...
Oncotelic Announces the launch of PDAO token
January 17, 2023 08:00 ET
|
Oncotelic Therapeutics, Inc.
- PDAO is to Revolutionize Decentralized Autonomous Organization (DAO) AGOURA HILLS, Calif., Jan. 17, 2023 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc (OTCQB:OTLC) ("Oncotelic", the...
Vyant Bio Engages LifeSci Capital to Explore Strategic Alternatives
January 04, 2023 16:15 ET
|
Vyant Bio, Inc.
CHERRY HILL, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex...
Crystal Research Update Highlights 100% Responders Rate in Mild to Moderate COVID-19 Trial
December 28, 2022 07:00 ET
|
BIOXYTRAN, INC.
Trial meets endpoints in safety and efficacyIND Letter from the CDSCO to optimize dosageEstablishment of an Indian Subsidiary to commercialize ProLectin-M BOSTON, MASSACHUSETTS, Dec. 28,...
AnPac Bio Reports 48.8% Decrease in Net Loss in First Half of 2022
December 19, 2022 16:15 ET
|
ANPAC BIO-MEDICAL SCIENCE CO., LTD.
PHILADELPHIA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the...
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
December 14, 2022 07:00 ET
|
BIOXYTRAN, INC.
BOSTON, MASSACHUSETTS, Dec. 14, 2022 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing oral and intravenous drugs to treat COVID-19...